Skip to main content
Erschienen in: Inflammation 2/2012

01.04.2012

Timing of Insulin Therapy Affects the Inflammatory Response in Endotoxemic Rats

verfasst von: Bo Zou, Qiyi Chen, Shaoqiu Tang, Tao Gao, Juanjuan Zhang, Fengchan Xi, Wenkui Yu

Erschienen in: Inflammation | Ausgabe 2/2012

Einloggen, um Zugang zu erhalten

Abstract

The aim of the present study was to determine whether timing of insulin administration influences the hepatic and serum proinflammatory and anti-inflammatory cytokines during endotoxemia stimulated by lipopolysaccharide (LPS). Eighty-one male Sprague–Dawley rats were divided into different time groups and insulin was given 30 min pre-LPS administration or hour 0, 1, 3, 6, 12, 24 after the induction of endotoxemia, respectively. Hepatic and serum proinflammatory cytokines IL-1β, IL-6, and TNF-α, and anti-inflammatory cytokine IL-10 were detected 24 and 48 h after the induction of endotoxemia. Compared with sham control rats, serum concentrations of proinflammatory cytokines IL-1β, IL-6, and TNF-α and anti-inflammatory cytokine IL-10 significantly increased on 24 and 48 h after induction of endotoxemia. Similarly, LPS administration also significantly increased the hepatic IL-1β, TNF-α, IL-6, and IL-10 protein concentration 48 h after LPS injection. Compared with levels in positive LPS controls animals receiving saline, on 24 and 48 h after LPS injection, insulin administrated ahead of 6 h after LPS injection significantly decreased the serum IL-1β, IL-6, and TNF-a concentration (P < 0.05), and significantly increased anti-inflammatory cytokine IL-10 concentration (P < 0.05); hepatic IL-1β and IL-6 expression were (P < 0.05) significantly decreased compared with levels in positive LPS controls. But, the significant decrease of hepatic TNF-a expression and significant increase of hepatic IL-10 were only seen in the animals in which insulin was administrated at 30 min pre-LPS or coadministrated with LPS. Insulin administrated 6 h after LPS injection lost the ability to significantly reduce serum or hepatic IL-1β, TNF-α, and IL-6 concentrations. Insulin has a protective role in systemic inflammatory response syndrome related to sepsis, such as downregulation of proinflammatory cytokines and upregulation of anti-inflammatory cytokine production. However, timing of insulin administrated may change its effect of inflammatory response in endotoxemic rats. Insulin administrated 6 h after LPS injection weaken the ability to protect inflammatory response related to sepsis.
Literatur
1.
Zurück zum Zitat van den Berghe, G., et al. 2001. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine 345(19): 1359–1367.PubMedCrossRef van den Berghe, G., et al. 2001. Intensive insulin therapy in the critically ill patients. The New England Journal of Medicine 345(19): 1359–1367.PubMedCrossRef
2.
Zurück zum Zitat Van den Berghe, G., et al. 2006. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354(5): 449–461.PubMedCrossRef Van den Berghe, G., et al. 2006. Intensive insulin therapy in the medical ICU. The New England Journal of Medicine 354(5): 449–461.PubMedCrossRef
3.
Zurück zum Zitat Brunkhorst, F.M., et al. 2008. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 358(2): 125–139.PubMedCrossRef Brunkhorst, F.M., et al. 2008. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. The New England Journal of Medicine 358(2): 125–139.PubMedCrossRef
4.
Zurück zum Zitat Finfer, S., et al. 2009. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 360(13): 1283–1297.PubMedCrossRef Finfer, S., et al. 2009. Intensive versus conventional glucose control in critically ill patients. The New England Journal of Medicine 360(13): 1283–1297.PubMedCrossRef
5.
Zurück zum Zitat Viardot, A., et al. 2007. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148(1): 346–353.PubMedCrossRef Viardot, A., et al. 2007. Potential antiinflammatory role of insulin via the preferential polarization of effector T cells toward a T helper 2 phenotype. Endocrinology 148(1): 346–353.PubMedCrossRef
6.
Zurück zum Zitat Jeschke, M.G., et al. 2004. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145(9): 4084–4093.PubMedCrossRef Jeschke, M.G., et al. 2004. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 145(9): 4084–4093.PubMedCrossRef
7.
Zurück zum Zitat Honiden, S., et al. 2008. Early versus late intravenous insulin administration in critically ill patients. Intensive Care Medicine 34(5): 881–887.PubMedCrossRef Honiden, S., et al. 2008. Early versus late intravenous insulin administration in critically ill patients. Intensive Care Medicine 34(5): 881–887.PubMedCrossRef
8.
Zurück zum Zitat Langouche, L., et al. 2007. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. Journal of Clinical Endocrinology and Metabolism 92(10): 3890–3897.PubMedCrossRef Langouche, L., et al. 2007. Effect of intensive insulin therapy on insulin sensitivity in the critically ill. Journal of Clinical Endocrinology and Metabolism 92(10): 3890–3897.PubMedCrossRef
9.
Zurück zum Zitat Osuchowski, M., et al. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. The Journal of Immunology 177(3): 1967.PubMed Osuchowski, M., et al. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. The Journal of Immunology 177(3): 1967.PubMed
10.
Zurück zum Zitat Van den Berghe, G., et al. 2003. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Critical Care Medicine 31(2): 359–366.PubMedCrossRef Van den Berghe, G., et al. 2003. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Critical Care Medicine 31(2): 359–366.PubMedCrossRef
11.
Zurück zum Zitat Zanotti, S., and A. Kumar. 2002. Cytokine modulation in sepsis and septic shock. Expert Opinion on Investigational Drugs 11(8): 1061.PubMedCrossRef Zanotti, S., and A. Kumar. 2002. Cytokine modulation in sepsis and septic shock. Expert Opinion on Investigational Drugs 11(8): 1061.PubMedCrossRef
12.
Zurück zum Zitat Casey, L., R. Balk, and R. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Annals of Internal Medicine 119(8): 771.PubMed Casey, L., R. Balk, and R. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Annals of Internal Medicine 119(8): 771.PubMed
13.
Zurück zum Zitat Jeschke, M.G., et al. 2005. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. Journal of Hepatology 42(6): 870–879.PubMedCrossRef Jeschke, M.G., et al. 2005. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. Journal of Hepatology 42(6): 870–879.PubMedCrossRef
14.
Zurück zum Zitat Frink, M., et al. 2009. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 17: 49.PubMedCrossRef Frink, M., et al. 2009. IL-6 predicts organ dysfunction and mortality in patients with multiple injuries. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 17: 49.PubMedCrossRef
15.
Zurück zum Zitat Rau, S., et al. 2007. Plasma interleukin 6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Veterinary Clinical Pathology 36(3): 253–260.PubMedCrossRef Rau, S., et al. 2007. Plasma interleukin 6 response is predictive for severity and mortality in canine systemic inflammatory response syndrome and sepsis. Veterinary Clinical Pathology 36(3): 253–260.PubMedCrossRef
16.
Zurück zum Zitat Barkhausen, T., et al. 2009. Insulin therapy induces changes in the inflammatory response in a murine 2-hit model. Injury 40(8): 806–814.PubMedCrossRef Barkhausen, T., et al. 2009. Insulin therapy induces changes in the inflammatory response in a murine 2-hit model. Injury 40(8): 806–814.PubMedCrossRef
17.
Zurück zum Zitat Debets, J., and R. Kampmeijer. 1989. Plasma tumor necrosis factor and mortality in critically ill septic patients. Critical Care Medicine 17(6): 489.PubMedCrossRef Debets, J., and R. Kampmeijer. 1989. Plasma tumor necrosis factor and mortality in critically ill septic patients. Critical Care Medicine 17(6): 489.PubMedCrossRef
18.
Zurück zum Zitat Leonidou, L., et al. 2007. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. Journal of Infection 55(4): 340–346.PubMedCrossRef Leonidou, L., et al. 2007. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. Journal of Infection 55(4): 340–346.PubMedCrossRef
19.
Zurück zum Zitat de Luca, C., and J. Olefsky. 2008. Inflammation and insulin resistance. FEBS Letters 582(1): 97–105.PubMedCrossRef de Luca, C., and J. Olefsky. 2008. Inflammation and insulin resistance. FEBS Letters 582(1): 97–105.PubMedCrossRef
20.
Zurück zum Zitat Fram, R., et al. 2010. Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children*. Critical Care Medicine 38(6): 1475.PubMedCrossRef Fram, R., et al. 2010. Intensive insulin therapy improves insulin sensitivity and mitochondrial function in severely burned children*. Critical Care Medicine 38(6): 1475.PubMedCrossRef
Metadaten
Titel
Timing of Insulin Therapy Affects the Inflammatory Response in Endotoxemic Rats
verfasst von
Bo Zou
Qiyi Chen
Shaoqiu Tang
Tao Gao
Juanjuan Zhang
Fengchan Xi
Wenkui Yu
Publikationsdatum
01.04.2012
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2012
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-011-9367-8

Weitere Artikel der Ausgabe 2/2012

Inflammation 2/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.